YiChang HEC ChangJiang Pharmaceutical マネジメント
マネジメント 基準チェック /34
YiChang HEC ChangJiang Pharmaceuticalの CEO はJuncai Jiangで、 May2015年に任命され、 の在任期間は 9.5年です。 の年間総報酬はCN¥ 2.57Mで、 18.7%給与と81.3%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.008%を直接所有しており、その価値はHK$ 623.81K 。経営陣と取締役会の平均在任期間はそれぞれ7.3年と7.3年です。
主要情報
Juncai Jiang
最高経営責任者
CN¥2.6m
報酬総額
| CEO給与比率 | 18.7% |
| CEO在任期間 | 9.5yrs |
| CEOの所有権 | 0.008% |
| 経営陣の平均在職期間 | 7.3yrs |
| 取締役会の平均在任期間 | 7.3yrs |
経営陣の近況
Recent updates
YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Strong Profits May Be Masking Some Underlying Issues
Oct 07
Should You Be Adding YiChang HEC ChangJiang Pharmaceutical (HKG:1558) To Your Watchlist Today?
Sep 19YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Popularity With Investors Under Threat As Stock Sinks 26%
May 29Do YiChang HEC ChangJiang Pharmaceutical's (HKG:1558) Earnings Warrant Your Attention?
Apr 23YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) P/S Is Still On The Mark Following 33% Share Price Bounce
Mar 01Investors Appear Satisfied With YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Prospects As Shares Rocket 33%
Mar 01YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Business Is Trailing The Industry But Its Shares Aren't
Jan 03YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Could Easily Take On More Debt
Sep 25Does YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Have A Healthy Balance Sheet?
Nov 25Is YiChang HEC ChangJiang Pharmaceutical (HKG:1558) A Risky Investment?
Mar 23Does This Valuation Of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Imply Investors Are Overpaying?
Oct 29Here's Why YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Has A Meaningful Debt Burden
Apr 13YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Analysts Just Cut Their EPS Forecasts Substantially
Mar 23YiChang HEC ChangJiang Pharmaceutical's(HKG:1558) Share Price Is Down 55% Over The Past Three Years.
Mar 13YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Is Growing Earnings But Are They A Good Guide?
Feb 20
Do Institutions Own YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Shares?
Feb 02YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Dec 26Key Things To Watch Out For If You Are After YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) 5.1% Dividend
Dec 13What Type Of Returns Would YiChang HEC ChangJiang Pharmaceutical's(HKG:1558) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Nov 30CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CN¥2b |
| Mar 31 2024 | n/a | n/a | CN¥2b |
| Dec 31 2023 | CN¥3m | CN¥482k | CN¥2b |
| Sep 30 2023 | n/a | n/a | CN¥2b |
| Jun 30 2023 | n/a | n/a | CN¥1b |
| Mar 31 2023 | n/a | n/a | CN¥608m |
| Dec 31 2022 | CN¥1m | CN¥600k | CN¥77m |
| Sep 30 2022 | n/a | n/a | -CN¥18m |
| Jun 30 2022 | n/a | n/a | -CN¥113m |
| Mar 31 2022 | n/a | n/a | -CN¥351m |
| Dec 31 2021 | CN¥1m | CN¥490k | -CN¥588m |
| Sep 30 2021 | n/a | n/a | -CN¥436m |
| Jun 30 2021 | n/a | n/a | -CN¥285m |
| Mar 31 2021 | n/a | n/a | CN¥277m |
| Dec 31 2020 | CN¥756k | CN¥229k | CN¥839m |
| Sep 30 2020 | n/a | n/a | CN¥1b |
| Jun 30 2020 | n/a | n/a | CN¥2b |
| Mar 31 2020 | n/a | n/a | CN¥2b |
| Dec 31 2019 | CN¥393k | CN¥222k | CN¥2b |
| Sep 30 2019 | n/a | n/a | CN¥2b |
| Jun 30 2019 | n/a | n/a | CN¥1b |
| Mar 31 2019 | n/a | n/a | CN¥1b |
| Dec 31 2018 | CN¥365k | CN¥209k | CN¥943m |
| Sep 30 2018 | n/a | n/a | CN¥961m |
| Jun 30 2018 | n/a | n/a | CN¥980m |
| Mar 31 2018 | n/a | n/a | CN¥813m |
| Dec 31 2017 | CN¥324k | CN¥194k | CN¥647m |
報酬と市場: Juncaiの 総報酬 ($USD 354.98K ) は、 Hong Kong市場 ($USD 481.54K ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Juncaiの報酬は過去 1 年間で 20% 以上増加しました。
CEO（最高経営責任者
Juncai Jiang (42 yo)
9.5yrs
在職期間
CN¥2,572,000
報酬
Mr. Juncai Jiang has been General Manager and Executive Director of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. since joining in May 2015. Mr. Jiang served as Deputy Head of the traditional Chinese med...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| GM & Executive Director | 9.5yrs | CN¥2.57m | 0.0076% HK$ 623.8k | |
| Head of the Sales Department | 10.5yrs | CN¥645.00k | データなし | |
| Deputy GM & Executive Director | 9.5yrs | CN¥2.71m | 0.0076% HK$ 627.9k | |
| Deputy GM & Executive Director | 9.5yrs | CN¥1.32m | 0.0076% HK$ 623.8k | |
| Executive Director | 1.2yrs | CN¥1.59m | データなし | |
| CFO & Head of Finance Department | 5.8yrs | CN¥480.38k | データなし | |
| Chief of Quality Division & Employee Representative Supervisor | 7.3yrs | データなし | 0.0036% HK$ 299.2k | |
| Joint Company Secretary | 6.1yrs | CN¥370.31k | データなし | |
| Joint Company Secretary | 2.8yrs | データなし | データなし |
7.3yrs
平均在職期間
43yo
平均年齢
経験豊富な経営陣: 1558の経営陣は経験豊富で経験豊富です（平均在職期間は7.3年）。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| GM & Executive Director | 9.5yrs | CN¥2.57m | 0.0076% HK$ 623.8k | |
| Deputy GM & Executive Director | 18.8yrs | CN¥2.71m | 0.0076% HK$ 627.9k | |
| Deputy GM & Executive Director | 6.4yrs | CN¥1.32m | 0.0076% HK$ 623.8k | |
| Executive Director | 1.2yrs | CN¥1.59m | データなし | |
| Chief of Quality Division & Employee Representative Supervisor | 7.3yrs | データなし | 0.0036% HK$ 299.2k | |
| Non-Executive Chairman | 9.5yrs | CN¥32.19m | 0.015% HK$ 1.2m | |
| Independent Non-Executive Director | 9.5yrs | CN¥100.00k | データなし | |
| Supervisor | 7.4yrs | データなし | 0.0076% HK$ 623.8k | |
| Chairman of the Board of Supervisors | 5.4yrs | データなし | データなし | |
| Independent Non Executive Director | 4.4yrs | CN¥100.00k | データなし | |
| Independent Non-Executive Director | 4.2yrs | CN¥340.00k | 0.00045% HK$ 37.0k |
7.3yrs
平均在職期間
46yo
平均年齢
経験豊富なボード: 1558の 取締役会 は 経験豊富 であると考えられます ( 7.3年の平均在任期間)。